Tenderwize
Retour à la recherche

Non-exclusive discount agreement for Propofol (N01AX10)

AOK Niedersachsen. Die Gesundheitskasse.·Hannover, Germany·Deadline Jun 27, 2028 · 630 days left·Open·Supplies·Framework
Structured notice only
Titre original de l'avis

Germany – Pharmaceutical products – Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V für die im Rahmen des Sprechstundenbedarfs in Niedersachsen verordnungs- und abgabefähigen Arzneimittel mit dem Wirkstoff Propofol (ATC-Code: N01AX10).

50/100

Score d'opportunité

Needs reviewLow complexity
SuppliesFrameworkOpen
Pourquoi ce score ?

Opportunité

50 / 100

Complexité

25 / 100

Facteurs de risque

The notice explicitly states it is not a public contract, limiting recourse to procurement review bodies. Legal challen...

No estimated value stated; potential for low or no revenue if prescribers do not choose the product.

No procurement documents available

Analyse approfondie du portefeuille

Analyse approfondie de l'adéquation entreprise

Utilise:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Informations clés

Pouvoir adjudicateur
AOK Niedersachsen. Die Gesundheitskasse.
Pays
Allemagne
CPV
33600000 - Pharmaceutical products
Date limite
Jun 27, 2028

Aperçu

Moderate opportunity

Faits clés

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration until Aug 2028
  • Enter into a non-exclusive discount agreement for the active ingredient Propofol (ATC N01AX10) for physician’s office supplies in Lower Saxony.
  • The agreement is under an open-house model: all qualified pharmaceutical entrepreneurs may join on identical terms, with no selection or negotiation.
Afficher le résumé complet

This is an open-house non-exclusive discount agreement (Rabattvertrag) for the active ingredient Propofol (ATC: N01AX10) for physician's office supplies (Sprechstundenbedarf) in Lower Saxony, Germany. The contracting authority is AOK Niedersachsen. The agreement is not a public procurement but a transparent open-house model where all qualified pharmaceutical entrepreneurs can join. The agreement period is from 01.09.2026 to 31.08.2028, with rolling entry possible on the first of each month. The first deadline for initial contracts is 28.07.2026. No estimated value is provided.

Risques

The notice explicitly states it is not a public contract, limiting recourse to procurement review bodies. Legal challen...

No estimated value stated; potential for low or no revenue if prescribers do not choose the product.

No procurement documents available

L'analyse peut être incomplète

Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.

Exigences clés

Technical

  • Must be a pharmaceutical entrepreneur as defined in §4(18) AMG or a consortium of such entrepreneurs.
  • Must have a registered seat in Germany, an EU member state, or an EEA state.
  • Local representatives can only participate if they themselves are pharmaceutical entrepreneurs.

Les exigences peuvent être incomplètes.

Acheteur

Localisation

Hannover, DEU

Identifiant

AOK- Niedersachsen. Die Gesundheitskasse

Activité

Health

Lots (1)

LOT-0000

Non-exclusive discount agreement for Propofol (N01AX10)

This lot covers the conclusion of non-exclusive discount agreements for Propofol preparations in Lower Saxony under the open-house model. All interested pharmaceutical entrepreneurs can join with uniform conditions. No selection or competition.

SuppliesFrameworkEU fundedElectronic submission

Localisation

DE929, Germany

Durée

Aug 2026 - Aug 2028

Catégorie

Pharmaceutical products

Date limite

Deadline Jun 27, 2028

Détails de la procédure

Date de publication
05 Jul 2026
Langues
German

Métadonnées de référence

Base juridique
32014L0024

Identifiants de référence

ID de l'appel d'offres
460781-2026

Appels d'offres similaires